It is noteworthy to mention that the preceding two studies by Shindo et al. and Chang et al. showed benefit with anti-PD1 even when it was administered late after the onset of sepsis, which strengthens its therapeutic implication [51,64]. This evidence concerns the gene PDCD1 and Sepsis.